These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12659665)

  • 1. Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.
    Hassenbusch SJ; Nardone EM; Levin VA; Leeds N; Pietronigro D
    Neoplasia; 2003; 5(1):9-16. PubMed ID: 12659665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
    Hamstra DA; Moffat BA; Hall DE; Young JM; Desmond TJ; Carter J; Pietronigro D; Frey KA; Rehemtulla A; Ross BD
    J Neurooncol; 2005 Jul; 73(3):225-38. PubMed ID: 15980973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DTI-015 produces cures in T9 gliosarcoma.
    Pietronigro D; Drnovsky F; Cravioto H; Ransohoff J
    Neoplasia; 2003; 5(1):17-22. PubMed ID: 12659666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.
    Jenkinson MD; Smith TS; Haylock B; Husband D; Shenoy A; Vinjamuri S; Walker C; Pietronigro D; Warnke PC
    J Neurooncol; 2010 Aug; 99(1):103-13. PubMed ID: 20063175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.
    Brandes AA; Scelzi E; Zampieri P; Rigon A; Rotilio A; Amista P; Berti F; Fiorentino MV
    Am J Clin Oncol; 1997 Aug; 20(4):364-7. PubMed ID: 9256890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
    Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
    Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.
    Bodell WJ; Giannini DD; Singh S; Pietronigro D; Levin VA
    J Neurooncol; 2003 May; 62(3):251-8. PubMed ID: 12777076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
    Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
    Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
    J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).
    Bodell WJ; Bodell AP; Giannini DD
    Neuro Oncol; 2007 Jan; 9(1):12-9. PubMed ID: 17018699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2004 May; 11(4):374-5. PubMed ID: 15080950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Vredenburgh J; Rich JN; Gururangan S; Badruddoja M; Herndon JE; Dowell JM; Friedman AH; Friedman HS
    Cancer; 2005 Jan; 103(2):329-38. PubMed ID: 15558802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
    Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
    J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose carmustine for high-grade gliomas in childhood.
    Bouffet E; Khelfaoui F; Philip I; Biron P; Brunat-Mentigny M; Philip T
    Cancer Chemother Pharmacol; 1997; 39(4):376-9. PubMed ID: 9025780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.